Most-read stories for the week include pieces on how Genworth struggled to generate new sales in 2018 and epileptic patients facing difficulty in getting their hands on a cannabis-based drug.
Select Demotech-rated Fla. insurers combine for $200M+ reserve build
Dozens of Florida-focused property insurers with financial strength ratings assigned by Demotech Inc. showed unfavorable prior-year reserve development in their 2018 annual statements.
Genworth's life division struggled to generate new sales in 2018
Genworth Financial Inc. generated little in the way of new product sales in 2018, as new premiums accounted for a tiny fraction of total premiums.
Auto Club Exchange, Farmers increased Calif. private auto rates in 2018
Auto Club Exchange Group unit Interinsurance Exchange of the Automobile Club received approval for a rate increase in California that may have been the most impactful hike nationwide in 2018 for a company outside of the four largest private auto insurers.
Demand for 1st cannabis-based drug meets distribution, insurance hurdles
Patients are demanding GW Pharmaceuticals PLC's Epidiolex for hard-to-treat epileptic conditions, but for some, the first cannabis-based medication approved by U.S. Food and Drug Administration has been hard to get.
Odds of US flood insurance reform looking up after bipartisan first step
House Democrats are looking to bipartisanship as the secret ingredient to pass a long-term overhaul of the National Flood Insurance Program that has eluded Congress since 2017.